SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce

7680697030028 CH-69703 V03AB35 15.01.0.
SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce
SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce
SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce
1 / 3
google

Details

Product number
6970303
CPT
-
Packaging group
10
Unit
Durchstechflasche(n)
Composition
sugammadexum 500 mg ut sugammadexum natricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 48.5 mg.

Articles (1)

Sugammadex Fresenius i.v. 500 mg/5 ml, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/08/2025
Professional SmPC
Français
09/08/2025
Professional SmPC
Italien
09/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
48.5 MG Substance HBESI

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
69703
Drug name
Sugammadex Fresenius i.v., Injektionslösung
Galenic form
LSINJ
ATC Code
V03AB35
Authorization status
Z
Dispensation category
B
First authorization
15/11/2024
Authorization expiration date
14/11/2029
IT number
15.01.0.
Domain
Human medicine
Field of application
Aufhebung der durch Rocuronium oder Vecuronium induzierten neuromuskulären Blockade. Bei Kindern und Adoleszenten wird die Anwendung nur bei durch Rocuronium induzierter neuromuskulärer Blockade empfohlen.

Packaging details

Description (FR)
SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce
Description (DE)
SUGAMMADEX Fresenius 500 mg/5ml Durchstf 10 Stk
Market launch
15/11/2024
Narcotic (BTM)
No

Other packaging sizes

SUGAMMADEX Fresenius 200 mg/2ml flac 10 pce
10 DUR
View